Microbiome influencers of checkpoint blockade–associated toxicity

Immunotherapy has greatly improved cancer outcomes, yet variability in response and off-target tissue damage can occur with these treatments, including immune checkpoint inhibitors (ICIs). Multiple lines of evidence indicate the host microbiome influences ICI response and risk of immune-related adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yinghong, Jenq, Robert R., Wargo, Jennifer A., Watowich, Stephanie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836236/
https://www.ncbi.nlm.nih.gov/pubmed/36622383
http://dx.doi.org/10.1084/jem.20220948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836236/
https://www.ncbi.nlm.nih.gov/pubmed/36622383
http://dx.doi.org/10.1084/jem.20220948

Ejemplares similares